Conclusions
OAC therapy was associated with reduced incidence of dementia in
patients with AF. However, on account of the high heterogeneity, low
SOE, and
no
statistical result in observational window subgroup analysis, the
results were limited. Further well-designed studies are needed to build
the reliable link between OAC use and the reduced risk of developing
dementia.